Synthesis of Novel Peptidyl Adenosine Antibiotic Analogs
63
13. Schweizer, P.; MoGrath, K.; Baozynskyj, L. The isolation and characterization of N-[9-(beta-D-
ribofuranosyl)-purin-6-ylcarbamoyl]glycine from yeast transfer RNA. Biochem. Biophys. Res. Commun.
1970, 40, 1046–1052.
14. a) Prasad, R.N.; Bariana, D.S.; Fung, A.; Savic, M.; Tietje, K.; Stein, H.H.; Brondyk, H.; Egan, R.S.
Modification of the 5’ position of purine nucleosides. 2. Synthesis and some cardiovascular proper-
ties of adenosine-5’-(N-substituted)carboxamides. J. Med. Chem. 1980, 23, 313–319. b) Bridges, A.J.;
Bruns, R.F.; Ortwine, D.F.; Priebe, S.R.; Szotek, D.L.; Trivedi, B.K. N6-[2-(3,5-dimethoxyphenyl)-2-
(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both
high affinity and high selectivity for the adenosine A2 receptor. J. Med. Chem. 1988, 31, 1282–1285.
c) Gallo-Rodriguez, C.; Ji, X.-D.; Melman, N.; Siegman, B.D.; Sanders, L.H.; Orlina, J.; Fischer, B.;
Pu, Q.; Olah, M.E.; Van Galen, P.J.M.; Stiles, G.L.; Jacobson, K.A. Structure–activity relationships
of N6-benzyladenosine-5’-uronamides as A3-selective adenosine agonists. J. Med. Chem. 1994, 37,
636–646. d) Wnuk, S.F.; Liu, S.; Yuan, C.S.; Borchardt, R.T.; Robins, M.J. Inactivation of S-adenosyl-
L-homocysteine hydrolase by amide and ester derivatives of adenosine-5’-carboxylic acid. J. Med.
Chem. 1996, 39, 4162–4166. e) de Zwart, M.; Kourounakis, A.; Kooijman, H.; Spek, A.L.; Link, R.;
von Frijtag Drabbe Ku¨nzel, J.K.; IJzerman, A.. 5’-N -substituted carboxamidoadenosines as agonists
for adenosine receptors. J. Med. Chem. 1999, 42, 1384–1392.
15. Prasad, R.N.; Fung, A.; Tietje, K.; Stein, H.H.; Brondyk, H.D. Modification of the 5’ position of purine
nucleosides. 1. Synthesis and biological properties of alkyladenosine-5’-carboxylates. J. Med. Chem.
1976, 19, 1180–1186.
16. Fritz, H.-J.; Machat, R.; Schmidt, R.R. Esters of nucleoside-5’-carboxylic acids as model compounds
for conformational analysis of nucleosides and nucleotides. Chem. Ber. 1972, 105, 642–649.
17. a) Hutchison, A.J.; Williams, M.; De Jesus, R.; Yokoyama, R.; Oei, H.H.; Ghai, G.R.; Webb, R.L.;
Zoganas, H.C.; Stone, G.A.; Jarvis, M.F. 2-(Arylalkylamino)adenosin-5’-uronamides: A new class of
highly selective adenosine A2 receptor ligands. J. Med. Chem. 1990, 33, 1919–1924. b) Homma, H.;
Watanabe, Y.; Abiru, T.; Murayama, T.; Nomura, Y.; Matsuda, A. Nucleosides and nucleotides. 112.
2-(1-Hexyn-1-yl)adenosine-5’-uronamides: A new entry of selective A2 adenosine receptor agonists
with potent antihypertensive activity. J. Med. Chem. 1992, 35, 2881–2890.
18. Robins, J.; Simon, L.N.; Stout, M.G.; Ivanovics, G.A.; Schweizer, M.P.; Rousseau, R.J.; Robins, R.K.
Nucleoside peptides. I. Synthesis of 5’-deoxy-5’-amino-5’-N-aminoacyl peptide derivatives of guano-
sine, adenosine, and 2’-deoxyadenosine and their effect of cell-free protein synthesis. J. Amer. Chem.
Soc., 1971, 98, 1474–1480.
19. Shabarova, Z.A.; Smirnov, V.D.; Prokof’ev, M.A. Peptide synthesis with the participation of 3’(2’)-O-
phenylalanyladenosine. Biokhimiya, 1964, 89, 502–507.
20. Herforth, C.; Wiesner, J.; Franke, S.; Golisade, A.; Jomaa, H.; Link, A. Antimalarial activity of n(6)-
substituted adenosine derivatives (part 2). J. Comb. Chem. 2002, 4, 302–314.
21. Aronov, A.M.; Gelb, M. Synthesis and structure-activity relationships of adenosine analogs as in-
hibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase. Modifications at positions 5’
and 8. Bioorg. Med. Chem. Lett. 1998, 8, 3505–3510.
22. Marasco, Jr. C.J.; Kramer, D.L.; Miller, J.; Porter, C.W.; Bacchi, C.J.; Rattendi, D.; Kucera, L.; Iyer,
N.; Bernacki, R.; Pera, P.; Sufrin, J.R. Synthesis and evaluation of analogues of 5’-([(Z)-4-amino-2-
butenyl]methylamino)-5’-deoxyadenosine as inhibitors of tumor cell growth, trypanosomal growth,
and HIV-1 infectivity. J. Med. Chem. 2002, 45, 5112–5122.
23. Moukha-chafiq, O.; Reynolds, R.C. Parallel solution-phase synthesis of an adenosine antibiotic analog
library. ACS Comb. Sci. 2013, 15, 147–152.
24. Epp, J.B.; Widlanski, T.S. Facile Preparation of Nucleoside-5’-carboxylic Acids. J. Org. Chem. 1999, 64,
293–295.
25. Atkinson, J.M.; Shelat, A.A.; Carcaboso, A.M.; Kranenburg, T.A.; Arnold, L.A.; Boulos, N.; Wright,
K.; Johnson, R.A.; Poppleton, H.; Mohankumar, K.M.; Feau, C.; Phoenix, T.; Gibson, P.; Zhu, L.;
Tong, Y.; Eden, C.; Ellison, D.; Priebe, W. Koul, D.; Yung, D.K.; Gajjar, A.; Stewart, C.F.; Guy, R.;
Gilbertson, R.J. An integrated in vitro and in vivo high-throughput screen identifies treatment leads
for ependymoma. Cancer Cell, 2011, 20, 384–399.
26. Guiguemde, W.A.; Shelat, A.A.; Bouck, D.; Duffy, S.; Crowther, G.J.; Davis, P.H.; Smithson, D.C.;
Connelly, M.; Clark, J.; Zhu, F.; Jime´nez-D´ıaz, M.B.; Martinez, M.S.; Wilson, E.B.; Tripathi, A.K.;
Gut, J.; Sharlow, E.R.; Bathurst, I.; El Mazouni, F.; Fowble, J.W.; Forquer, I.; McGinley, P.L.; Castro,
S.; Angulo-Barturen, I.; Ferrer, S.; Rosenthal, P.J.; DeRisi, J. L.; Sullivan, D.J.; Lazo, J.S.; Roos, D.S.;
Riscoe, M.K.; Phillips, M.A.; Rathod, P.K.; Van Voorhis, W.S.; Avery, V.M.; Guy, R.K. Chemical genetics
of Plasmodium falciparum. Nature. 2010, 456, 311–315.